Mechanism of cytotoxic action of perfluorinated acids. III. Disturbance in Ca2+ homeostasis

Toxicology and Applied Pharmacology

Volumn 251, Issue 2, 2011, Pages 163-168

  Kleszczyński, Konrad ^a   Składanowski, Andrzej C ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Apoptosis; Calcium homeostasis; Cell signaling; HCT116 cells; Mitochondria; Perfluorinated acid

Indexed keywords

CALCIUM; PERFLUORO COMPOUND;

ACIDIFICATION; ARTICLE; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL DEATH; CELL STRAIN HCT116; CONTROLLED STUDY; CYTOPLASM; CYTOSOL; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIPOPHILICITY; MEMBRANE POTENTIAL; MITOCHONDRION;

CALCIUM; CELL MEMBRANE; CYTOTOXINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUOROCARBONS; HCT116 CELLS; HOMEOSTASIS; HUMANS; OCTANOIC ACIDS;

EID: 79851516500     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.01.002     Document Type: Article

References (37)

1. Abdellatif A.G., Preat V., Taper H.S., Roberfroid M. The modulation of rat liver carcinogenesis by perfluorooctanoic acid, a peroxisome proliferator. Toxicol. Appl. Pharmacol. 1991, 111:530-537.
2. Abramov A.Y., Duchen M.R. Actions of ionomycin, 4-BrA23187 and a novel electrogenic Ca2+ ionophore on mitochondria in intact cells. Cell Calcium 2003, 33:101-112.
3. Arudine M., Tymianski M. Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium 2003, 34:325-337.
4. Bano D., Dinsdale D., Cabrera-Socorro A., Maida S., Lambacher N., McColl B., Ferrando-May E., Hengartner M.O., Nicotera P. Alteration of the nuclear pore complex in Ca2+-mediated cell death. Cell Death Differ. 2010, 17:119-133.
5. Beal M.F. Mitochondrial dysfunction in neurodegenerative diseases. Biochim. Biophys. Acta 1998, 1366:211-223.
6. Butenhoff J.L., York R., Seacat A., Luebker D. Perfluorooctanesulfonate-induced perinatal mortality in rat pups is associated with a steep dose-response. Toxicol. Sci. 2002, 66(S-1):25. (Abstract 120).
7. Duchen M.R. Mitochondria and calcium: from cell signaling to cell death. J. Physiol. 2000, 529:57-68.
8. Ferri K.F., Kroemer G. Organelle-specific initiation of cell death pathways. Nat. Cell Biol. 2001, 3:E255-E263.
9. Green D.R., Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004, 305:626-629.
10. Griffith F.D., Long J.E. Animal toxicity studies with ammonium perfluorooctanoate. Am. Ind. Hyg. Assoc. J. 1980, 41:576-583.
11. Grote P., Schaeuble K., Ferrando-May E. Commuting (to) suicide: an update on nucleocytoplasmic transport in apoptosis. Arch. Biochem. Biophys. 2007, 462:156-161.
12. Harada K., Xu F., Ono K., Ijima T., Koizumi A. Effects of PFOS and PFOA on L-type Ca2+ currents in guinea-pig ventricular myocytes. Biochem. Biophys. Res. Commun. 2005, 329:487-494.
13. Hu W., Jones P.D., DeCoen W., King L., Fraker P., Newsted J., Giesy J.P. Alterations in cell membrane properties caused by perfluorinated compounds. Comp. Biochem. Physiol. C 2003, 135:77-88.
14. Keller B.J., Marsman D.S., Popp J.A., Thurman R.G. Several nongenotoxic carcinogens uncouple mitochondrial oxidative phosphorylation. Biochim. Biophys. Acta 1992, 1102:237-244.
15. Kennedy G.L., Hall G.T., Brittelli M.R., Barnes J.R., Chen H.C. Inhalation toxicity of ammonium perfluorooctanoate. Food Chem. Toxicol. 1986, 24:1325-1329.
16. Kleszczyński K., Składanowski A.C. Mechanism of cytotoxic action of perfluorinated acids. I. Alteration in plasma membrane potential and intracellular pH level. Toxicol. Appl. Pharmacol. 2009, 234:300-305.
17. Kleszczyński K., Gardzielewski P., Mulkiewicz E., Stepnowski P., Składanowski A.C. Analysis of structure-cytotoxicity in vitro relationship (SAR) for perfluorinated carboxylic acids. Toxicol. in Vitro 2007, 21:1206-1211.
18. Kleszczyński K., Stepnowski P., Składanowski A.C. Mechanism of cytotoxic action of perfluorinated acids. II. Disruption of mitochondrial bioenergetics. Toxicol. Appl. Pharmacol. 2009, 235:182-190.
19. Krieger C., Duchen M.R. Mitochondria, Ca2+ and neurodegenerative disease. Eur. J. Pharmacol. 2002, 447:177-188.
20. Liao C., Wang T., Cui L., Zhou Q., Duan S., Jiang G. Changes in synaptic transmission, calcium current, and neurite growth by perfluorinated compounds are dependent on the chain length and functional group. Environ. Sci. Technol. 2009, 43:2099-2104.
21. Martin J.W., Mabury S.A., Solomon K.R., Muir D.C. Dietary accumulation of perfluorinated acids in juvenile rainbow trout (Oncorhynchus mykiss). Environ. Toxicol. Chem. 2003, 22:189-195.
22. Martinou J.C., Desagher S., Antonsson B. Cytochrome c release from mitochondria: all or nothing. Nat. Cell Biol. 2000, 2:E41-E43.
23. Mei-Jie J., Tsung-I P., Russel J.R., Shou-Bin J., Hong-Yueh W., Shiau-Ting W. Visualisation of the antioxidative effects of melatonin at the mitochondrial level during oxidative stress-induced apoptosis of rat brain astrocytes. J. Pineal Res. 2004, 37:55-70.
24. Ohmori K., Kudo N., Katayama K., Kawashima Y. Comparison of the toxicokinetics between perfluorocarboxylic acids with different carbon chain length. Toxicology 2003, 184:135-140.
25. Olsen G.W., Burris J.M., Mandel J.H., Zobel L.R. Serum perfluorooctane sulfonate and hepatic and lipid clinical chemistry tests in fluorochemicals production employees. J. Occup. Environ. Med. 1999, 41:799-806.
26. Panaretakis T., Shabalina I.G., Grandér D., Shoshan M.C., DePierre J.W. Reactive oxygen species and mitochondria mediate the induction of apoptosis in human hepatoma HepG2 cells by the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid. Toxicol. Appl. Pharmacol. 2001, 173:56-64.
27. Parone P.A., James D., Martinou J.C. Mitochondria: regulating the inevitable. Biochimie 2002, 84:105-111.
28. Parrish J., Li L., Klotz K., Ledwich D., Wang X., Xue D. Mitochondrial endonuclease G is important in apoptosis in C. elegans. Nature 2001, 412:90-94.
29. Pinton P., Ferrari D., Di Virgilio F., Pozzan T., Rizzutto R. Molecular machinery and signaling events in apoptosis. Drug Dev. Res. 2001, 52:558-570.
30. Sargent J., Seffl R. Properties of perfluorinated liquids. Fed. Proc. 1970, 29:1699-1703.
31. Shabalina I.G., Panaretakis T., Bergstrand A., DePierre J.W. Effects of the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid, on apoptosis in human hepatoma HepG2 cells. Carcinogenesis 1999, 20:2237-2246.
32. Sohlenius A.K., Eriksson A.M., Högström C., Kimland M., DePierre J.W. Perfluorooctane sulfonic acid is a potent inducer of peroxisomal acid beta-oxidation and other activities known to be affected by peroxisome proliferators in mouse liver. Pharmacol. Toxicol. 1993, 72:90-93.
33. Sohlenius A.K., Andersson K., Bergstrand A., Spydevold O., DePierre J.W. Effects of perfluorooctanoic acid-a potent peroxisome proliferator in rat-on Morris hepatoma 7800C1 cells, a rat cell line. Biochim. Biophys. Acta 1994, 1213:63-74.
34. Strasser A., O'Connor L., Dixit V.M. Apoptosis signaling. Ann. Rev. Biochem. 2000, 69:217-267.
35. Szegezdi E., Logue S.E., Gorman A.M., Samali A. Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep. 2006, 7:880-885.
36. Upham B.L., Deocampo N.D., Wurl B., Trosko J.E. Inhibition of gap junctional intercellular communication by perfluorinated acids is dependent on the chain length of the fluorinated tail. Int. J. Cancer 1998, 78:491-495.
37. Vanden Heuvel J.P. Peroxisome proliferator-activated receptors (PPARs) and carcinogenesis. Toxicol. Sci. 1999, 47:1-8.